Daunorubicin citrate - CAS 1884557-85-0

Daunorubicin (Daunomycin) citrate, a potent anti-tumor anthracycline antibiotic, acts as a topoisomerase II inhibitor. It effectively inhibits DNA and RNA synthesis, diminishes cancer cell viability, and promotes apoptosis and necrosis. This cytotoxic compound is utilized in researching a range of cancers, such as leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, and Wilms' tumor, as well as infections [1] [2] [4] [5].

DNA/RNA Synthesis, Apoptosis, ADC Cytotoxin, Autophagy, Topoisomerase, Antibacterial, Antibiotic

Autophagy, DNA Damage/DNA Repair, Cell Cycle/Checkpoint, Antibody-drug Conjugate/ADC Related, Microbiology/Virology, Apoptosis

1884472

C33H37NO17

719.64

OC(=O)CC(O)(CC(O)=O)C(O)=O.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O

-20°C

Ice Packs

Small Compound